Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received December 22, 2005
- Accepted February 6, 2006
- Published online March 1, 2006.
Copyright & Usage
Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- HANS PRENEN1,
- CHRISTOPHE DEROOSE2,
- PETER VERMAELEN2,
- RAF SCIOT3,
- MARIA DEBIEC-RYCHTER4,
- SIGRID STROOBANTS2,
- LUC MORTELMANS2,
- PATRICK SCHÖFFSKI1 and
- ALLAN VAN OOSTEROM1
- 1Laboratory for Experimental Oncology (LEO), Department of General Medical Oncology, Catholic University Leuven, B-3000 Leuven, Belgium
- 2Department of Nuclear Medicine, Catholic University Leuven, B-3000 Leuven, Belgium
- 3Department of Pathology, Catholic University Leuven, B-3000 Leuven, Belgium
- 4Department of Center for Human Genetics, Catholic University Leuven, B-3000 Leuven, Belgium
- Correspondence to: Hans Prenen, MD, Laboratory for Experimental Oncology, Department of General Medical Oncology, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. Tel: 00 32 (0)16.34.62.85, Fax: 00 32 (0)16.34.69.01, e-mail: hans.prenen{at}uz.kuleuven.ac.be
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal
- Establishment and Characterization of a Novel Xenograft Model of Human Gastrointestinal Stromal Tumor in Mice
- Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer
- Establishment and Characterization of a Human Gastrointestinal Stromal Tumour (GIST) Xenograft in Athymic Nude Mice
- Inhibitors of Deacetylases Suppress Oncogenic KIT Signaling, Acetylate HSP90, and Induce Apoptosis in Gastrointestinal Stromal Tumors
- High Efficacy of Panobinostat Towards Human Gastrointestinal Stromal Tumors in a Xenograft Mouse Model
- Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET